About Tubby-related protein 3
Tubby-related protein 3 (TULP3) is a protein
from Homo sapiens identified by UniProt accession
O75386, 442 residues long.
MolForge cross-references it against 0 known binders and
216 disease associations.
Target properties
| Protein name | Tubby-related protein 3 |
| UniProt accession | O75386 |
| Gene | TULP3 |
| Organism | Homo sapiens |
| Length | 442 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (216)
Diseases linked to this target (Open Targets).
- hepatorenocardiac degenerative fibrosis · score 0.70
- neurodegenerative disease · score 0.48
- ciliopathy · score 0.37
- leukocyte count · score 0.27
- mean corpuscular volume · score 0.25
- mean corpuscular hemoglobin concentration · score 0.23
- mean corpuscular hemoglobin · score 0.22
- genetic disorder · score 0.19
- mean reticulocyte volume · score 0.19
- neutrophil count · score 0.17
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O75386-F1 | alphafold | PREDICTED | 72.25 | — |
Amino-acid sequence (442 residues)
MEASRCRLSP SGDSVFHEEM MKMRQAKLDY QRLLLEKRQR KKRLEPFMVQ PNPEARLRRA KPRASDEQTP LVNCHTPHSN VILHGIDGPA AVLKPDEVHA PSVSSSVVEE DAENTVDTAS KPGLQERLQK HDISESVNFD EETDGISQSA CLERPNSASS QNSTDTGTSG SATAAQPADN LLGDIDDLED FVYSPAPQGV TVRCRIIRDK RGMDRGLFPT YYMYLEKEEN QKIFLLAARK RKKSKTANYL ISIDPVDLSR EGESYVGKLR SNLMGTKFTV YDRGICPMKG RGLVGAAHTR QELAAISYET NVLGFKGPRK MSVIIPGMTL NHKQIPYQPQ NNHDSLLSRW QNRTMENLVE LHNKAPVWNS DTQSYVLNFR GRVTQASVKN FQIVHKNDPD YIVMQFGRVA DDVFTLDYNY PLCAVQAFGI GLSSFDSKLA CE
Explore Tubby-related protein 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets